Global Musculoskeletal Disorders Drugs Market Report 2019 Featuring F. Hoffmann-La Roche, GlaxosmithKline, Pfizer, Abbott Laboratories, Daiichi Sankyo – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Musculoskeletal Disorders Drugs Market Report 2019″ report has been added to ResearchAndMarkets.com’s offering.

Global Musculoskeletal Disorders Drugs Market Report 2019 provides the strategists, marketers and senior management with the critical information they need to assess the global musculoskeletal disorders drugs market.

Where is the largest and fastest growing market for the musculoskeletal disorders drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Musculoskeletal Disorders Drugs market global report answers all these questions and many more.

The musculoskeletal disorders drugs market consists of sales of musculoskeletal disorders drugs and related services by entities (organizations, sole traders and partnerships) that produce musculoskeletal disorders drugs to treat musculoskeletal disorders such as arthritis, osteoporosis, osteomalacia, and other disorders. This industry includes establishments that produce drugs to treat rheumatoid arthritis, muscle relaxants to reduce muscle pain, and other drugs used in treating osteoarthritis, analgesics drugs, immunosuppressives.

Asia Pacific was the largest region in the global musculoskeletal disorders drugs market, accounting for 41% of the market in 2018. North America was the second largest region accounting for 30% of the global musculoskeletal disorders drugs market. Africa was the smallest region in the global musculoskeletal disorders drugs market.

Introduction of advanced pain free drug delivery technologies is promoting the use of musculoskeletal drugs. Drug delivery systems refer to methods or processes used to administer a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Drug delivery products such as intrathecal pumps are being used to deliver muscle relaxants such as baclofen directly into spinal cord to provide instant relief. Intra-Articular drug delivery systems are also widely being used to administer medicines to treat arthritis.

In addition, these products reduce spasticity symptoms and lower the side effects caused by oral spasticity medications.

Key Topics Covered:

1. Executive Summary

2. Report Structure

3. Musculoskeletal Disorders Drugs Market Characteristics

3.1. Market Definition

3.2. Key Segmentations

4. Musculoskeletal Disorders Drugs Market Product Analysis

4.1. Leading Products/ Services

4.2. Key Features and Differentiators

4.3. Development Products

5. Musculoskeletal Disorders Drugs Market Supply Chain

5.1. Supply Chain

5.2. Distribution

5.3. End Customers

6. Musculoskeletal Disorders Drugs Market Customer Information

6.1. Customer Preferences

6.2. End Use Market Size and Growth

7. Musculoskeletal Disorders Drugs Market Trends And Strategies

8. Musculoskeletal Disorders Drugs Market Size And Growth

8.1. Market Size

8.2. Historic Market Growth, Value ($ Billion)

8.2.1. Drivers Of The Market

8.2.2. Restraints On The Market

8.3. Forecast Market Growth, Value ($ Billion)

8.3.1. Drivers Of The Market

8.3.2. Restraints On The Market

9. Musculoskeletal Disorders Drugs Market Regional Analysis

9.1. Global Musculoskeletal Disorders Drugs Market, 2018, By Region, Value ($ Billion)

9.2. Global Musculoskeletal Disorders Drugs Market, 2014 – 2022, Historic And Forecast, By Region

9.3. Global Musculoskeletal Disorders Drugs Market, Growth And Market Share Comparison, By Region

10. Musculoskeletal Disorders Drugs Market Segmentation

10.1. Global Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2014 – 2022, Value ($ Billion)

10.1.1. Drugs For Rheumatoid Arthritis

10.1.2. Muscle Relaxants

10.1.3. Others – Musculoskeletal Disorders Drugs

11. Musculoskeletal Disorders Drugs Market Metrics

11.1. Musculoskeletal Disorders Drugs Market Size, Percentage Of GDP, 2014 – 2022, Global

11.2. Per Capita Average Musculoskeletal Disorders Drugs Market Expenditure, 2014 – 2022, Global

Companies Mentioned

• F. Hoffmann-La Roche Ltd
• GlaxosmithKline Plc
• Pfizer Inc
• Abbott Laboratories Inc
• Daiichi Sankyo Company

For more information about this report visit https://www.researchandmarkets.com/r/dm0cz2

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics: Musculoskeletal Disorders Drugs